Cancer Center

Dendreon Rises After Winning Approval for Cancer Drug (Update2)
April 29 (Bloomberg) — Dendreon Corp. won approval for its first product, a vaccine to fight prostate cancer, after a three-year battle with U.S. regulators. Shares surged the most in a year in New York trading.

Read more on Bloomberg

Related posts

• How to Fight Cancer & Win
• The Cancer-Fighting Kitchen: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
• The Cancer Survivor’s Guide: Foods That Help You Fight Back
• Heart Drugs Show Promise for Fighting Colon Cancer
• Beat Cancer Naturally – Natural Therapies to Conquer Cancer Today